FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Claude Camelin

Research Profile

Chemicals & Drugs

Anatomy

Concepts & Ideas

Structure-Activity Relationship

Phenomena

Protein Binding

Living Beings

Procedures

Surface Plasmon Resonance

Devices

Biosensing Techniques

Co-author Network

Publications

TOP 3
M Walter; Y von Coburg; K Isensee; K Sander; Xavier Ligneau; Jean-Claude Camelin; Jean-Charles Schwartz; Holger Stark
Azole derivatives as histamine H3 receptor antagonists, part I: thiazol-2-yl ethers.
M Walter; K Isensee; T Kottke; Xavier Ligneau; Jean-Claude Camelin; Jean-Charles Schwartz; Holger Stark
Azole derivatives as histamine H3 receptor antagonists, part 2: C-C and C-S coupled heterocycles.
Kerstin Sander; Tim Kottke; Claas Hoffend; Miriam Walter; Lilia Weizel; Jean-Claude Camelin; Xavier Ligneau; Erich H Schneider; Roland Seifert; Jean-Charles Schwartz; Holger Stark
First metal-containing histamine H3 receptor ligands.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Claude Camelin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: M Walter; Y von Coburg; K Isensee; K Sander; Xavier Ligneau; Jean-Claude Camelin; Jean-Charles Schwartz; Holger Stark
Azole derivatives as histamine H3 receptor antagonists, part I: thiazol-2-yl ethers.
Bioorganic & medicinal chemistry letters 2010;20(19):5879-82.
2010: M Walter; K Isensee; T Kottke; Xavier Ligneau; Jean-Claude Camelin; Jean-Charles Schwartz; Holger Stark
Azole derivatives as histamine H3 receptor antagonists, part 2: C-C and C-S coupled heterocycles.
Bioorganic & medicinal chemistry letters 2010;20(19):5883-6.
2010: Kerstin Sander; Tim Kottke; Claas Hoffend; Miriam Walter; Lilia Weizel; Jean-Claude Camelin; Xavier Ligneau; Erich H Schneider; Roland Seifert; Jean-Charles Schwartz; Holger Stark
First metal-containing histamine H3 receptor ligands.
Organic letters 2010;12(11):2578-81.
2010: Kerstin Sander; Yvonne von Coburg; Jean-Claude Camelin; Xavier Ligneau; Oliver Rau; Manfred Schubert-Zsilavecz; Jean-Charles Schwartz; Holger Stark
Acidic elements in histamine H(3) receptor antagonists.
Bioorganic & medicinal chemistry letters 2010;20(5):1581-4.
2009: K Isensee; M Amon; A Garlapati; A Galaparti; Xavier Ligneau; Jean-Claude Camelin; M Capet; Jean-Charles Schwartz; Holger Stark
Fluorinated non-imidazole histamine H3 receptor antagonists.
Bioorganic & medicinal chemistry letters 2009;19(8):2172-5.
2008: Mickaël Jean; Jacques Renault; Jean-Claude Camelin; Nicolas Levoin; Denis Danvy; Holger Stark; Marc Capet; Philippe Uriac
A solid phase parallel synthesis of diverse amides as dopamine D3 receptor ligands.
Journal of enzyme inhibition and medicinal chemistry 2008;23(5):588-92.
2007: Michael Amon; Xavier Ligneau; Jean-Claude Camelin; Isabelle Berrebi-Bertrand; Jean-Charles Schwartz; Holger Stark
Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands.
ChemMedChem 2007;2(5):708-16.
2007: Xavier Ligneau; D Perrin; L Landais; Jean-Claude Camelin; T P G Calmels; Isabelle Berrebi-Bertrand; J-M Lecomte; Régis Parmentier; Christelle Anaclet; Jian-Sheng Lin; Valérie Bertaina-Anglade; Christophe Drieu La Rochelle; F d'Aniello; Agnès Rouleau; Florence Gbahou; Jean-Michel Arrang; C Robin Ganellin; Holger Stark; Walter Schunack; Jean-Charles Schwartz
BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology.
The Journal of pharmacology and experimental therapeutics 2007;320(1):365-75.
2003: Jeanne Flavigny; Philippe Robert; Jean-Claude Camelin; Ketty Schwartz; Lucie Carrier; Isabelle Berrebi-Bertrand
Biomolecular interactions between human recombinant beta-MyHC and cMyBP-Cs implicated in familial hypertrophic cardiomyopathy.
Cardiovascular research 2003;60(2):388-96.
2002: Isabelle Lefrere; Pierre De Coppet; Jean-Claude Camelin; Soazig Le Lay; Nathalie Mercier; Nabil A Elshourbagy; Antoine Bril; Isabelle Berrebi-Bertrand; Bruno Feve; Stéphane Krief
Neuropeptide AF and FF modulation of adipocyte metabolism. Primary insights from functional genomics and effects on beta-adrenergic responsiveness.
The Journal of biological chemistry 2002;277(42):39169-78.
2001: I Berrebi-Bertran; Philippe Robert; Jean-Claude Camelin; Antoine Bril; Michel Souchet
The gamma-subunit of (Na+,K+)-ATPase: a representative example of human single transmembrane protein with a key regulatory role.
Cellular and molecular biology (Noisy-le-Grand, France) 2001;47(2):285-96.
1998: Isabelle Berrebi-Bertrand; Michel Souchet; Jean-Claude Camelin; M P Laville; Thierry P G Calmels; Antoine Bril
Biophysical interaction between phospholamban and protein phosphatase 1 regulatory subunit GM.
FEBS letters 1998;439(3):224-30.
1998: Isabelle Berrebi-Bertrand; N Brument-Larignon; Jean-Claude Camelin; M J Quiniou; Antoine Bril
Relationship between biochemical and functional effects of protein phosphatase 1 inhibitors in rabbit cardiac skinned fibers.
Journal of molecular and cellular cardiology 1998;30(10):1945-54.
1997: P Lahouratate; J Guibert; Jean-Claude Camelin; I Bertrand
Specific inhibition of cardiac and skeletal muscle sarcoplasmic reticulum Ca2+ pumps by H-89.
Biochemical pharmacology 1997;54(9):991-8.
1997: Isabelle Berrebi-Bertrand; P Lahouratate; V Lahouratate; Jean-Claude Camelin; J Guibert; Antoine Bril
Mechanism of action of sarcoplasmic reticulum calcium-uptake activators--discrimination between sarco(endo)plasmic reticulum Ca2+ ATPase and phospholamban interaction.
European journal of biochemistry / FEBS 1997;247(3):801-9.